Meeting the Challenges of

Managing Comorbidities

in Patients with HBV

HBV Virus surrounded by organs and pelvis.
Global Education Group Logo

This activity is jointly provided by Global Education Group and the Asian Health Foundation.
This activity is supported by an independent educational grant from Gilead Sciences, Inc.


Please complete the pre-test before proceeding to the activity. It is available at the following link.


Chronic hepatitis B (CHB) is a serious cause of liver-related morbidity and mortality in the United States. Compounding the consequences of CHB is the high prevalence of liver- and non-liver-related comorbidities. In both clinical cohort and claim database studies, CHB patients are presenting at an older age and with more comorbidities, including fatty liver, cirrhosis, decompensation, HCC, hepatitis D virus (HDV) infection, chronic kidney disease, and metabolic and bone disorders. Clinicians practicing in Asian American communities are challenged to stay current with advances in not only CHB antiviral treatment options and their practical clinical applications, but also emerging therapeutic options and preventive measures and management approaches for patients with medical comorbidities. The primary goal of this CME-certified activity is to improve outcomes for individuals with CHB by increasing awareness and knowledge of the prevalence of medical comorbidities and their impact on treatment selection and long-term patient management among health care providers practicing in Asian American communities.


Professor of Medicine, Gastroenterology and Hepatology
Stanford University Medical Center
Stanford, CA


Physician and physician assistant providers practicing in communities that serve Asian American patients at risk for HBV.


Upon completion of this program, participants will be better able to:

  • Describe the changing demographics of CHB and the risks of common medical comorbidities
  • Employ current clinical practice guidelines for CHB to appropriately screen and test for HBV infection
  • Differentiate among available treatment agents in terms of efficacy, safety, dosing, side-effect profile, and the impact on common comorbidities


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and the Asian Health Foundation. Global is accredited by the ACCME to provide continuing medical education for physicians.

* This CME-certified activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


AAPA accepts certificates of participation for educational activities certified for 1.0 AMA PRA Category 1 Credit(s)™. from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1 hour of Category 1 credit for completing this program.


The system, such as a laptop, desktop, or Android/IOS smart device, must be able to play audio and run a version of Chrome, Firefox, Internet Explorer, Microsoft Edge, or Safari that is less than 3 years old.


Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient-care recommendations.

Name of Faculty or Presenter Reported Financial Relationship
Paul Kwo, MD Advisory Board: Abbvie; Bristol-Myers Squibb; Gilead Sciences, Inc.; Merck & Co.; Quest Diagnostics Consultant/Independent Contractor: Janssen Data and Safety Monitoring Board (DSMB) Grant/Research Support: (Grants Paid to Institution): Assembly; Bristol-Myers Squibb; Gilead Sciences, Inc.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager Reported Financial Relationship
Lindsay Borvansky Nothing to disclose
Ashley Cann Nothing to disclose
Andrea Funk Nothing to disclose
Lindsay Knight Nothing to disclose
James Murphy Nothing to disclose
Alexis Weinstein Nothing to disclose


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Asian Health Foundation do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


For information about the accreditation of this program, please contact Global at 303-395-1782 or


There is no fee for this CME-certified activity.


This activity was released on April 15, 2019, and is valid for one year. Requests for credit must be made no later than April 15, 2020.


In order to receive credit for this activity, the participant must listen to the entire activity and then complete the post-survey, post-test, evaluation, and request for credit. The link is made available upon completion of the activity.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation or patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.